Navigation Links
3SBio Inc. to Report 2009 Third Quarter Earnings on November 12, 2009
Date:10/27/2009

SHENYANG, China, Oct. 27 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release financial results for the third quarter ended September 30, 2009 after the US market closes on Thursday, November 12, 2009.

Following the earnings announcement, 3SBio's senior management will host a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 9:00 pm (Beijing/Hong Kong) on Friday, November 13, 2009 to discuss its 2009 third quarter financial results and recent business activity. The conference call may be accessed using the dial-in numbers below:

    Conference ID: 38479039

    Local dial-in:
    China - landline 800-819-0121
    China - mobile 400-620-8038

    International toll-free dial-in:
    Hong Kong 800930346
    United Kingdom 080-8234-6646
    United States 1-866-519-4004

    International toll dial-in: 65-6735-7955

    Replay-Conference ID: 38479039

A telephone replay will be available two hours after the call until November 20, 2009, at:

    International dial-in: +61-2-8235-5000
    United States dial-in: 1-866-214-5335

Webcast

A live webcast of the conference will be available on the investor relations page of 3SBio's website at http://bbs.3sbio.com/en/News/xinvestors.aspx and at http://tinyurl.com/yf93ntk . A replay of the webcast will be available within one hour after the conclusion of the call.

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit
'/>"/>

SOURCE 3SBio Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. 3SBio Inc. to Hold 2009 Annual General Meeting on October 12, 2009
2. 3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor
3. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results
4. 3SBio Inc. Receives Official Recognition as a High-Tech Enterprise
5. 3SBio Inc. to Report 2008 Fourth Quarter and Full Year Earnings on March 11, 2009
6. 3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer
7. 3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference
8. 3SBio Inc. Announces Third Quarter 2008 Results
9. 3SBio Inc. Files for SFDA Approval of NuLeusin
10. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
11. 3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2014)... and SAN ANTONIO , Dec. 12, ... announced the presentation of data at the San Antonio ... study evaluating epoetin alfa plus best supportive care (BSC) ... with metastatic breast cancer receiving standard chemotherapy. This non-inferiority ... to rule out a 15 percent or greater increase ...
(Date:12/12/2014)... Graphite Metallizing Corporation, the manufacturer of ... process equipment, has appointed Kirk Staller as Sales Engineering ... Staller holds a B.S. degree from Purdue University and ... place, much of it with a manufacturer of centrifugal ... office. , “We are pleased to have ...
(Date:12/12/2014)... (PRWEB) December 11, 2014 Electronic ... market for claims management and supply chain management ... mode of transactions. The benefits associated with the ... reduced time of transactions has helped improve the ... , Browse 70 market data tables and 107 ...
(Date:12/12/2014)... MA (PRWEB) December 11, 2014 ... delivery products for ophthalmology and wound care applications. ... LayerBio a $150,000 small business innovation research grant ... , Glaucoma is the leading cause of irreversible ... 2.2 million people suffer from glaucoma. The ...
Breaking Biology Technology:Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 2Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 3Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 4Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 5Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 6Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 7Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 8Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 9Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 10Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 11Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 12Kirk Staller Joins Graphite Metallizing Corporation 2The Global EDIS Market Was Valued at $312.00 Million in 2014 - New Report by MarketsandMarkets 2The Global EDIS Market Was Valued at $312.00 Million in 2014 - New Report by MarketsandMarkets 3The Global EDIS Market Was Valued at $312.00 Million in 2014 - New Report by MarketsandMarkets 4MIT Spinoff Receives NSF Grant to Develop Nanoparticle Glaucoma Therapy 2
... March 11, 2011 Apexigen, Inc., an emerging biopharmaceutical ... announced today that its partner, Simcere Pharmaceutical Group (NYSE: ... China, filed an Investigational New Drug (IND) application with ... to evaluate APX003 (also known as BD0801) as a ...
... dreaming of mobile devices that run longer on lighter, ... granted. University of Illinois engineers have developed a ... uses 100 times less energy than similar available memory. ... battery life between charges. Led by electrical and ...
... Technology, Inc. (“ACT”; OTC Bulletin Board: ACTC ... announced today that the Committee for Orphan Medicinal Products ... a positive opinion of ACT,s human embryonic stem cell ... an orphan medicinal product for the treatment of Stargardt,s ...
Cached Biology Technology:Apexigen Announces the Filing by its Partner, Simcere Pharmaceutical Group, of First IND 2New technology would dramatically extend battery life for mobile devices 2New technology would dramatically extend battery life for mobile devices 3ACT Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for hESC-Derived RPE Cells for Treatment of Stargardt's Disease 2ACT Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for hESC-Derived RPE Cells for Treatment of Stargardt's Disease 3
(Date:11/18/2014)... 2014  The Secure Identity & Biometrics Association ... announce the formation of The Airport Entry and ... Identity and Biometric Entry and Exit Solutions Framework ... support from BORDERPOL, the international non-profit organization that ... expertise regarding border security, traveler and migration systems. ...
(Date:11/18/2014)... The Parenteral Drug Association (PDA) today confirmed that ... and at least seven more will participate in the upcoming ... Hotel in Washington D.C. , Dec. 2-4. ... support from the regulatory agencies in the United ... our effort to help advance the use of metrics in ...
(Date:11/15/2014)... , Nov. 13, 2014  While we may still ... Doctor McCoy used in "Star Trek" to gain instant access ... designed to work with smartphones and tablets for monitoring and ... the healthcare world. This may seem a tad Orwellian to ... to adopt some of these technological opportunities into their healthcare ...
Breaking Biology News(10 mins):Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4
... colors seem to show up later and laterif at ... carbon dioxide in the atmosphere for prolonging the growing ... good news for forestry industries. Writing in ... Michigan Technological University Professor David F. Karnosky and colleagues ...
... WASHINGTON -- The National Academy of Sciences (NAS) will ... in the areas of biology, chemistry, solar physics, ecology, ... The awards and recipients for 2008 are: ARCTOWSKI ... as well as a gift of $60,000 to an ...
... today that it has been named an American ... Surgery Center of Excellence. The ASMBS Center ... demonstrated track record of favorable outcomes in bariatric ... expertise of our experienced surgeons and our institutional ...
Cached Biology News:Forests could benefit when fall color comes late 2Academy honors 13 for major contributions to science 2Academy honors 13 for major contributions to science 3Academy honors 13 for major contributions to science 4Academy honors 13 for major contributions to science 5Pennsylvania Hospital recognized for excellence in bariatric surgery 2
... cDNA normalization is essential for ... using high-throughput approaches, such as EST ... Most normalization methods are not well ... cDNA. The Evrogen TRIMMER kit, though, ...
... years of expertise in the field of ... the most powerful systems on the market. ... 000 in-microplate tests requiring incubation and washing ... modules (such as worktable shaker incubators, reader,washer), ...
... 6 delivers enhanced statistics and statistical ... quality improvement managers. As an accepted ... 6 simplifies statistics for novice users ... by experts. It offers a powerful ...
Glycerol-based mounting medium for immunofluorescence microscopy. Formulated to retard photobleaching of fluorochromes such as fluorescein and rhodamine. Product can also be used as a diluent for fl...
Biology Products: